Hiroaki Itoh

Hiroaki Itoh

Auto-generated profile, based on publicly available information

Hiroaki Itoh

Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

21 February 2010 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
MIMasayuki Inoue
Masayuki Inoue
NSNaoki Shinohara
Naoki Shinohara
STShintaro Tanabe
Shintaro Tanabe
TTTomoaki Takahashi
Tomoaki Takahashi
KOKen Okura
Ken Okura
SMShigeru Matsuoka
Shigeru Matsuoka

1 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
YTYuri Takada
Yuri Takada
HIHiroaki Itoh
Hiroaki Itoh
APAtmika Paudel
Atmika Paudel
SPSuresh Panthee
Suresh Panthee
Hiroshi HamamotoHiroshi Hamamoto
Hiroshi Hamamoto
MIMasayuki Inoue
Masayuki Inoue
Gramicidin A (1) is a peptide antibiotic that disrupts the transmembrane ion concentration gradient by forming an ion channel in a lipid bilayer. Although long used clinically, it is limited to topical application because of its strong hemolytic activity and mammalian cytotoxicity, likely arising from the common ion transport mechanism. Here we report an integrated high-throughput strategy for discovering analogues of 1 with altered biological activity profiles. The 4096 analogue structures are designed to maintain the charge-neutral, hydrophobic, and channel forming properties of 1. Synthesis of the analogues, tandem mass spectrometry sequencing, and 3 microscale screenings enable us to identify 10 representative analogues. Re-synthesis and detailed functional evaluations find that all 10 analogues share a similar ion channel function, but have different cytotoxic, hemolytic, and antibacterial activities. Our large-scale structure-activity relationship studies reveal the feasibility of developing analogues of 1 that selectively induce toxicity toward target organisms.

5 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HIHiroaki Itoh
Hiroaki Itoh
KTKotaro Tokumoto
Kotaro Tokumoto
TKTakuya Kaji
Takuya Kaji
APAtmika Paudel
Atmika Paudel
SPSuresh Panthee
Suresh Panthee
MIMasayuki Inoue
Masayuki Inoue
Lysocin E, a 37-membered natural depsipeptide, induces rapid bacteriolysis in methicillin-resistant Staphylococcus aureus via a unique menaquinone-dependent mechanism, presenting a promising therapeutic lead. Despite the great medical importance, exploring the potential utility of its derivatives as new platform structures for antibiotic development has remained a significant challenge. Here, we report a high-throughput strategy that enabled the preparation of thousands of analogues of lysocin E and large-scale structure-activity relationship analyses. We integrate 26-step total synthesis of 2401 cyclic peptides, tandem mass spectrometry-sequencing, and two microscale activity assays to identify 23 candidate compounds. Re-synthesis of these candidates shows that 11 of them (A1–A11) exhibit antimicrobial activity superior or comparable to that of lysocin E, and that lysocin E and A1–A11 share l-Leu-6 and l-Ile-11. Therefore, the present strategy allows us to efficiently decipher biologically crucial residues and identify potentially useful agents for the treatment of infectious diseases.

11 October 2017 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
HIHiroaki Itoh
Hiroaki Itoh
KTKotaro Tokumoto
Kotaro Tokumoto
TKTakuya Kaji
Takuya Kaji
APAtmika Paudel
Atmika Paudel
SPSuresh Panthee
Suresh Panthee
MIMasayuki Inoue
Masayuki Inoue
WAP-8294A2 (lotilibcin, 1) is a potent antibiotic with superior in vivo efficacy to vancomycin against methicillin-resistant Staphylococcus aureus (MRSA). Despite the great medical importance, its molecular mode of action remains unknown. Here we report the total synthesis of complex macrocyclic peptide 1 comprised of 12 amino acids with a β-hydroxy fatty-acid chain, and its deoxy analogue 2. A full solid-phase synthesis of 1 and 2 enabled their rapid assembly and the first detailed investigation of their functions. Compounds 1 and 2 were equipotent against various strains of Gram-positive bacteria including MRSA. We present evidence that the antimicrobial activities of 1 and 2 are due to lysis of the bacterial membrane, and their membrane-disrupting effects depend on the presence of menaquinone, an essential factor for the bacterial respiratory chain. The established synthetic routes and the menaquinone-targeting mechanisms provide valuable information for designing and developing new antibiotics based on their structures.

13 January 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
HIHiroaki Itoh
Hiroaki Itoh
KMKensuke Miura
Kensuke Miura
KKKoichi Kamiya
Koichi Kamiya
TYTomoya Yamashita
Tomoya Yamashita
MIMasayuki Inoue
Masayuki Inoue